Bird flu cases are still rising in the U.S. as the virus continues to devastate poultry farms. More than 145 million chickens, ducks, turkeys and other fowl have been slaughtered across the United ...

All in the eyes: High resolution retinal maps aid disease diagnoses. ScienceDaily . Retrieved February 16, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250204132223.htm ...

However, where it fell short was with respect to the failure at week 36 with the phase 2b SYMMETRY study, which used EFX to treat compensated cirrhosis patients due to MASH stage F4 fibrosis.

Google Maps will display the name “Gulf of America” instead of the “Gulf of Mexico” for U.S. users once official government sources are updated to reflect the name change ordered by ...

Google Maps will reflect President Trump’s changes in the United States and will show the Gulf of America and Mount McKinley, Fox News Digital has learned. Google will make the changes once ...

Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity. ScienceDaily . Retrieved February 17, 2025 from www.sciencedaily.com / releases ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study offers one available option: bariatric surgery. Weight loss operations ...

Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...